Preve raises $2.2 million in seed funding to combat physiotherapy dropouts, led by Carthona Capital. The funding will help tackle patient abandonment in rehabilitation using AI.
Amount Raised
$2.2 Million
Round Type
Seed
SydneyBiotechnologyHealth CareArtificial IntelligenceInvestors
Description
Preve has secured $2.2 million in seed funding to address a widespread issue in healthcare: patients abandoning their physiotherapy. The round was led by Carthona Capital, supported by other investors including Startmate and Archangel. The startup aims to utilize AI to improve patient engagement and recovery outcomes. This funding will enable Preve to develop innovative solutions to keep patients on track with their rehabilitation.
Quick answer
Preve raised $2.2 Million in a Seed round, dated May 22, 2025. Investors: Startmate, Archangel, Black Sheep Capital, Alexey Mitko, Charlie Gearside and Carthona Capital. Preve is based in Sydney, New South Wales, Australia.
- How much did Preve raise?
- Preve raised $2.2 Million in a Seed round on May 22, 2025.
- Who invested in Preve?
- Startmate, Archangel, Black Sheep Capital, Alexey Mitko, Charlie Gearside and Carthona Capital are named as investors in this round.
- What does Preve do?
- Preve is a startup focused on addressing the issue of people abandoning physiotherapy treatment before completing their recovery.
- Where is Preve based and how big is it?
- Preve is based in Sydney, New South Wales, Australia.
- Who are the decision-makers at Preve?
- Fundz holds 1 contact at Preve. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Preve that raised within 45 days of this round, from Fundz verified event records.
- Imagene raised $23M (Series B) on July 4, 2025.
- Quiver Bioscience raised $2.1M (Grant) on July 1, 2025.
- ForSight Robotics raised $125M (Series B) on June 24, 2025.
- Axiles Bionics raised $7M (Series A) on June 24, 2025.
- Shuttle Pharmaceutical Holdings raised $4.3M (Seed) on June 20, 2025.
- Lyrebird Health raised $8.9M (Funding Round) on June 18, 2025.
Who to call at Preve, and when
A new round usually means Preve is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Preve raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Preve, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Preve. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Preve raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Preve raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.